Recruit

uMed Recruit

The digital patient recruitment platform that enrols patients for trials in days, not years.

What We Do

More patients
Faster enrolment
Greater diversity

Meet your recruitment target on time, every time

We increase monthly patients randomised by an average of 3x, empowering you to better meet your recruitment timeframe.

Minimise screening failures

We automatically pre-screen patients with EHR information and digital questionnaires so that ~80% of patients referred to sites by uMed go on to be randomised.

Increase population diversity

We can identify and tailor our outreach towards ethnic minorities, achieving up to 5x more representation of minoritised groups.

Access novel patient populations

We identify patients via primary care that are interested in clinical research but overlooked by traditional recruitment methods.

"uMed’s ability to rapidly identify large populations of eligible participants using EHR, combined with automated communication sent on behalf of the patient’s healthcare provider, has meant we’ve seen a significant increase and speed in enrollment each month since working with them."

Professor Alastair Noyce

Consultant Neurologist and Researcher at QMUL's Wolfson Institute of Population Health

AMAZING WORK TEAM! The UK is not the easiest of countries to recruit patients in the desired population at the moment so well done and continue the great work!

Global Study Director, AstraZeneca

Professor Alastair Noyce

Consultant Neurologist and Researcher at QMUL's Wolfson Institute of Population Health

Professor Alastair Noyce

Consultant Neurologist and Researcher at QMUL's Wolfson Institute of Population Health

Why we're different

Integration with top 2 GP EHR software platforms

The only platform to integrate with a network of over 450 primary care practices which facilitates easy GP approval to reach out to patients.

EHR & hospitalisation data linkage

uMed can augment GP EHR data with secondary care HES data into a complete study data set, which would otherwise require manual collection.

Automatic patient outreach on behalf of recognised GP

The only platform to automatically reach out to approved patients via an SMS on behalf of their recognised GP.

How we make a difference

The Challenge

85% of trials are delayed due to slow recruitment. Having to move the goalposts of a study is common and expensive for the sponsor.

The Solution

uMed increases monthly randomised patients by an average of 3 times.

The Challenge

CROs and major clinical sites struggle with access to patients and often recycle the same patient populations for each trial.

Case Studies

Parkinson's Disease

PREDICT-PD

Learn how uMed linked aggregated health record data to build a highly relevant and diverse cohort of study candidates.

Respiratory

CARES Study

Discover how uMed supported this study with full end-to-end patient recruitment alongside device distribution, training, and data collection and aggregation.

Hypertension

PERSONAL COVID BP

Find out how uMed helped successfully recruit 73% of referred patients into this study within 21 days, not only meeting but far exceeding the study’s recruitment objectives...

How we work

We find the right patients from the start

Using health record data we are able to filter by specific inclusion and exclusion criteria, generating only the most relevant patient cohorts, therefore reducing screening failures at the site.

Additional screening

Patients complete a screening questionnaire based on the inclusion/exclusion criteria for the trial. Criteria that can’t be screened via questionnaire is screened and validated via phone by a registered nurse

Automatically engage potential trial participants

Once a potential trial participant is approved by our provider partner, we automatically reach out to the patient via SMS, email and/or letter to invite them to participate. The patient can find all the information on the study and consent electronically to be contacted by the trial site.

Workload for the provider practice is minimal

Therefore the full process, from initial patient identification to engagement, is extremely quick and efficient.

We’ve seen a significant increase and speed in enrolment each month since working with uMed, which is enabling our research to progress at a pace we never expected to achieve

Dr Alistair Noyce

Consultant Neurologist & Researcher at QMUL